{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:14:29Z","timestamp":1790561669932,"version":"4.1.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SBF005\\1083"],"award-info":[{"award-number":["SBF005\\1083"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019418","name":"NIHR Maudsley Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215747\/Z\/19\/Z"],"award-info":[{"award-number":["215747\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["094849\/Z\/10\/Z"],"award-info":[{"award-number":["094849\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_U120097115"],"award-info":[{"award-number":["MC_U120097115"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The D2 dopamine receptor (D2R) is the primary site of the therapeutic action of antipsychotics and is involved in essential brain functions relevant to schizophrenia, such as attention, memory, motivation, and emotion processing. Moreover, the gene coding for D2R (\n                    <jats:italic>DRD2<\/jats:italic>\n                    ) has been associated with schizophrenia at a genome-wide level. Recent studies have shown that a polygenic co-expression index (PCI) predicting the brain-specific expression of a network of genes co-expressed with\n                    <jats:italic>DRD2<\/jats:italic>\n                    was associated with response to antipsychotics, brain function during working memory in patients with schizophrenia, and with the modulation of prefrontal cortex activity after pharmacological stimulation of D2 receptors. We aimed to investigate the relationship between the\n                    <jats:italic>DRD2<\/jats:italic>\n                    gene network and in vivo striatal dopaminergic function, which is a phenotype robustly associated with psychosis and schizophrenia. To this aim, a sample of 92 healthy subjects underwent\n                    <jats:sup>18<\/jats:sup>\n                    F-DOPA PET and was genotyped for genetic variations indexing the co-expression of the\n                    <jats:italic>DRD2<\/jats:italic>\n                    -related genetic network in order to calculate the PCI for each subject. The PCI was significantly associated with whole striatal dopamine synthesis capacity (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.038). Exploratory analyses on the striatal subdivisions revealed a numerically larger effect size of the PCI on dopamine function for the associative striatum, although this was not significantly different than effects in other sub-divisions. These results are in line with a possible relationship between the\n                    <jats:italic>DRD2<\/jats:italic>\n                    -related co-expression network and schizophrenia and extend it by identifying a potential mechanism involving the regulation of dopamine synthesis. Future studies are needed to clarify the molecular mechanisms implicated in this relationship.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-16442-6","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T06:02:46Z","timestamp":1658556166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A polygenic score indexing a DRD2-related co-expression network is associated with striatal dopamine function"],"prefix":"10.1038","volume":"12","author":[{"given":"Enrico","family":"D\u2019Ambrosio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio F.","family":"Pardi\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Dahoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Sportelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Taurisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Jauhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rogdaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A. P.","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Froudist-Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bonoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T. R.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"16442_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"J-M Beaulieu","year":"2011","unstructured":"Beaulieu, J.-M. & Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182\u2013217 (2011).","journal-title":"Pharmacol. Rev."},{"key":"16442_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/1179069518779829","author":"Mishra","year":"2018","unstructured":"Mishra, Singh, & Shukla,. Physiological and functional basis of dopamine receptors and their role in neurogenesis: Possible implication for Parkinson\u2019s disease. J. Exp. Neurosci. https:\/\/doi.org\/10.1177\/1179069518779829 (2018).","journal-title":"J. Exp. Neurosci."},{"key":"16442_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pneurobio.2004.09.004","volume":"74","author":"Pezze","year":"2004","unstructured":"Pezze, & Feldon,. Mesolimbic dopaminergic pathways in fear conditioning. Prog. Neurobiol. 74, 301\u2013320 (2004).","journal-title":"Prog. Neurobiol."},{"key":"16442_CR4","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1073\/pnas.97.14.7673","volume":"97","author":"Seeman","year":"2000","unstructured":"Seeman, & Kapur,. Schizophrenia: More dopamine, more D2 receptors. Proc. Natl. Acad. Sci. 97, 7673\u20137675 (2000).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR5","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1073\/pnas.72.11.4376","volume":"72","author":"P Seeman","year":"1975","unstructured":"Seeman, P., Chau-Wong, M., Tedesco, J. & Wong, K. Brain receptors for antipsychotic drugs and dopamine: Direct binding assays. Proc. Natl. Acad. Sci. 72, 4376\u20134380 (1975).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature25758","volume":"555","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature 555, 269\u2013273 (2018).","journal-title":"Nature"},{"key":"16442_CR7","doi-asserted-by":"publisher","first-page":"107704","DOI":"10.1016\/j.neuropharm.2019.107704","volume":"172","author":"SJ Kaar","year":"2019","unstructured":"Kaar, S. J., Natesan, S., McCutcheon, R. & Howes, O. D. Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology 172, 107704 (2019).","journal-title":"Neuropharmacology"},{"key":"16442_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41588-018-0059-2","volume":"50","author":"AF Pardi\u00f1as","year":"2018","unstructured":"Pardi\u00f1as, A. F. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381\u2013389 (2018).","journal-title":"Nat. Genet."},{"key":"16442_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"S Ripke","year":"2014","unstructured":"Ripke, S. et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421\u2013427 (2014).","journal-title":"Nature"},{"key":"16442_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon, R. A., Krystal, J. H. & Howes, O. D. Dopamine and glutamate in schizophrenia: Biology, symptoms and treatment. World Psychiatry 19, 15\u201333 (2020).","journal-title":"World Psychiatry"},{"key":"16442_CR11","doi-asserted-by":"publisher","first-page":"e9348","DOI":"10.1371\/journal.pone.0009348","volume":"5","author":"A Bertolino","year":"2010","unstructured":"Bertolino, A. et al. Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS ONE 5, e9348 (2010).","journal-title":"PLoS ONE"},{"key":"16442_CR12","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/npp.2015.5","volume":"40","author":"G Blasi","year":"2015","unstructured":"Blasi, G. et al. Variation in dopamine D2 and serotonin 5-HT2A receptor genes is associated with working memory processing and response to treatment with antipsychotics. Neuropsychopharmacology 40, 1600\u20131608 (2015).","journal-title":"Neuropsychopharmacology"},{"key":"16442_CR13","doi-asserted-by":"publisher","first-page":"e95997","DOI":"10.1371\/journal.pone.0095997","volume":"9","author":"A Di Giorgio","year":"2014","unstructured":"Di Giorgio, A.\u00a0et al. DRD2\/CHRNA5 interaction on prefrontal biology and physiology during working memory. PLoS ONE 9, e95997 (2014).","journal-title":"PLoS ONE"},{"key":"16442_CR14","doi-asserted-by":"publisher","first-page":"e747","DOI":"10.1038\/tp.2016.22","volume":"6","author":"BS Gluskin","year":"2016","unstructured":"Gluskin, B. S. & Mickey, B. J. Genetic variation and dopamine D2 receptor availability: A systematic review and meta-analysis of human in vivo molecular imaging studies. Transl. Psychiatry 6, e747 (2016).","journal-title":"Transl. Psychiatry"},{"key":"16442_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neubiorev.2017.01.006","volume":"74","author":"JJ Luykx","year":"2017","unstructured":"Luykx, J. J., Broersen, J. L. & de Leeuw, M. The DRD2 rs1076560 polymorphism and schizophrenia-related intermediate phenotypes: A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 74, 214\u2013224 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"16442_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/schbul\/sbr128","volume":"39","author":"F Sambataro","year":"2013","unstructured":"Sambataro, F. et al. DRD2 genotype-based variation of default mode network activity and of its relationship with striatal DAT binding. Schizophr. Bull. 39, 206\u2013216 (2013).","journal-title":"Schizophr. Bull."},{"key":"16442_CR17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/mp.2017.208","volume":"23","author":"CE Wiers","year":"2018","unstructured":"Wiers, C. E. et al. Association of genetic ancestry with striatal dopamine D2\/D3 receptor availability. Mol. Psychiatry 23, 1711\u20131716 (2018).","journal-title":"Mol. Psychiatry"},{"key":"16442_CR18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","volume":"169","author":"EA Boyle","year":"2017","unstructured":"Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: From polygenic to omnigenic. Cell 169, 1177\u20131186 (2017).","journal-title":"Cell"},{"key":"16442_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41398-018-0200-0","volume":"8","author":"J Chen","year":"2018","unstructured":"Chen, J., Cao, H., Meyer-Lindenberg, A. & Schwarz, E. Male increase in brain gene expression variability is linked to genetic risk for schizophrenia. Transl. Psychiatry 8, 140 (2018).","journal-title":"Transl. Psychiatry"},{"key":"16442_CR20","doi-asserted-by":"publisher","first-page":"eaat8127","DOI":"10.1126\/science.aat8127","volume":"362","author":"MJ Gandal","year":"2018","unstructured":"Gandal, M. J. et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science 362, eaat8127 (2018).","journal-title":"Science"},{"key":"16442_CR21","doi-asserted-by":"publisher","first-page":"eaat7615","DOI":"10.1126\/science.aat7615","volume":"362","author":"M Li","year":"2018","unstructured":"Li, M. et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 362, eaat7615 (2018).","journal-title":"Science"},{"key":"16442_CR22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/s41593-021-00887-5","volume":"24","author":"CL Hartl","year":"2021","unstructured":"Hartl, C. L. et al. Coexpression network architecture reveals the brain-wide and multiregional basis of disease susceptibility. Nat. Neurosci. 24, 1313\u20131323 (2021).","journal-title":"Nat. Neurosci."},{"key":"16442_CR23","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1126\/science.1057264","volume":"291","author":"P McGuffin","year":"2001","unstructured":"McGuffin, P., Riley, B. & Plomin, R. Toward behavioral genomics. Science 291, 1232\u20131249 (2001).","journal-title":"Science"},{"key":"16442_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrg3934","volume":"16","author":"NN Parikshak","year":"2015","unstructured":"Parikshak, N. N., Gandal, M. J. & Geschwind, D. H. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat. Rev. Genet. 16, 441\u2013458 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"16442_CR25","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.03.230227","author":"G Pergola","year":"2020","unstructured":"Pergola, G. et al. A miR-137-related biological pathway of risk for Schizophrenia is associated with human brain emotion processing. bioRxiv https:\/\/doi.org\/10.1101\/2020.08.03.230227 (2020).","journal-title":"bioRxiv"},{"key":"16442_CR26","doi-asserted-by":"publisher","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","volume":"95","author":"MB Eisen","year":"1998","unstructured":"Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. 95, 14863\u201314868 (1998).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR27","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/nn.4399","volume":"19","author":"M Fromer","year":"2016","unstructured":"Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. 19, 1442\u20131453 (2016).","journal-title":"Nat. Neurosci."},{"key":"16442_CR28","doi-asserted-by":"publisher","first-page":"201717135","DOI":"10.1073\/pnas.1717135115","volume":"115","author":"L Fazio","year":"2018","unstructured":"Fazio, L. et al. Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory. Proc. Natl. Acad. Sci. 115, 201717135 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/gbb.12106","volume":"13","author":"Gaiteri","year":"2014","unstructured":"Gaiteri, Ding, French, Tseng, & Sibille,. Beyond modules and hubs: The potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav. 13, 13\u201324 (2014).","journal-title":"Genes Brain Behav."},{"key":"16442_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biopsych.2019.03.981","volume":"86","author":"G Pergola","year":"2019","unstructured":"Pergola, G. et al. Prefrontal co-expression of schizophrenia risk genes is associated with treatment response in patients. Biol. Psychiatry 86, 45\u201355 (2019).","journal-title":"Biol. Psychiatry"},{"key":"16442_CR31","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41380-018-0304-1","volume":"25","author":"E Radulescu","year":"2020","unstructured":"Radulescu, E. et al. Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain. Mol. Psychiatry 25, 791\u2013804 (2020).","journal-title":"Mol. Psychiatry"},{"key":"16442_CR32","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1523\/JNEUROSCI.0786-19.2019","volume":"40","author":"S Torretta","year":"2020","unstructured":"Torretta, S. et al. NURR1 and ERR1 modulate the expression of genes of a DRD2 coexpression network enriched for schizophrenia risk. J. Neurosci. 40, 932\u2013941 (2020).","journal-title":"J. Neurosci."},{"key":"16442_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbw139","author":"S van Dam","year":"2017","unstructured":"van Dam, S., V\u00f5sa, U., van der Graaf, A., Franke, L. & de Magalh\u00e3es, J. P. Gene co-expression analysis for functional classification and gene\u2013disease predictions. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbw139 (2017).","journal-title":"Brief Bioinform."},{"key":"16442_CR34","doi-asserted-by":"publisher","first-page":"D77","DOI":"10.1093\/nar\/gkm840","volume":"36","author":"T Obayashi","year":"2008","unstructured":"Obayashi, T. et al. COXPRESdb: A database of coexpressed gene networks in mammals. Nucleic Acids Res. 36, D77\u2013D82 (2008).","journal-title":"Nucleic Acids Res."},{"key":"16442_CR35","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1038\/tp.2016.253","volume":"7","author":"G Pergola","year":"2017","unstructured":"Pergola, G. et al. DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia. Transl. Psychiatry 7, e1006 (2017).","journal-title":"Transl. Psychiatry"},{"key":"16442_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04434-5","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy, V. et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature https:\/\/doi.org\/10.1038\/s41586-022-04434-5 (2022).","journal-title":"Nature"},{"key":"16442_CR37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/cercor\/10.11.1078","volume":"10","author":"JH Callicott","year":"2000","unstructured":"Callicott, J. H. et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb. Cortex 10, 1078\u20131092 (2000).","journal-title":"Cereb. Cortex"},{"key":"16442_CR38","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1038\/s41467-021-23694-9","volume":"12","author":"U Braun","year":"2021","unstructured":"Braun, U. et al. Brain network dynamics during working memory are modulated by dopamine and diminished in schizophrenia. Nat. Commun. 12, 3478 (2021).","journal-title":"Nat. Commun."},{"key":"16442_CR39","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/cercor\/bhy022","volume":"29","author":"P Selvaggi","year":"2019","unstructured":"Selvaggi, P. et al. Genetic variation of a DRD2 co-expression network is associated with changes in prefrontal function after D2 receptors stimulation. Cereb. Cortex 29, 1162\u20131173 (2019).","journal-title":"Cereb. Cortex"},{"key":"16442_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0006-8993(93)90878-Q","volume":"609","author":"RM Kessler","year":"1993","unstructured":"Kessler, R. M. et al. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride. Brain Res. 609, 237\u2013243 (1993).","journal-title":"Brain Res."},{"key":"16442_CR41","doi-asserted-by":"publisher","first-page":"201809298","DOI":"10.1073\/pnas.1809298115","volume":"115","author":"MM Nour","year":"2018","unstructured":"Nour, M. M. et al. Dopaminergic basis for signaling belief updates, but not surprise, and the link to paranoia. Proc. Natl. Acad. Sci. 115, 201809298 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.biopsych.2018.09.010","volume":"85","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon, R. A. et al. Mesolimbic dopamine function is related to salience network connectivity: An integrative positron emission tomography and magnetic resonance study. Biol. Psychiatry 85, 368\u2013378 (2019).","journal-title":"Biol. Psychiatry"},{"key":"16442_CR43","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle, M. et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. 93, 9235\u20139240 (1996).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR44","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham, A. et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. 97, 8104\u20138109 (2000).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR45","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1093\/brain\/awt264","volume":"136","author":"OD Howes","year":"2013","unstructured":"Howes, O. D. et al. Midbrain dopamine function in schizophrenia and depression: A post-mortem and positron emission tomographic imaging study. Brain 136, 3242\u20133251 (2013).","journal-title":"Brain"},{"key":"16442_CR46","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes, O. D. et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment: Meta-analysis of imaging studies. Arch. Gen. Psychiatry 69, 776\u2013786 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"16442_CR47","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41380-018-0042-4","volume":"24","author":"S Jauhar","year":"2019","unstructured":"Jauhar, S. et al. Determinants of treatment response in first-episode psychosis: An 18F-DOPA PET study. Mol. Psychiatry 24, 1502\u20131512 (2019).","journal-title":"Mol. Psychiatry"},{"key":"16442_CR48","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/schbul\/sbx180","volume":"44","author":"R McCutcheon","year":"2017","unstructured":"McCutcheon, R., Beck, K., Jauhar, S. & Howes, O. D. Defining the locus of dopaminergic dysfunction in schizophrenia: A meta-analysis and test of the mesolimbic hypothesis. Schizophrenia Bull. 44, 1301\u20131311 (2017).","journal-title":"Schizophrenia Bull."},{"key":"16442_CR49","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.1523\/JNEUROSCI.0805-07.2007","volume":"27","author":"Y Kumakura","year":"2007","unstructured":"Kumakura, Y. et al. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: An [18F]fluorodopa\/positron emission tomography study. J. Neurosci. 27, 8080\u20138087 (2007).","journal-title":"J. Neurosci."},{"key":"16442_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nn804","volume":"5","author":"A Meyer-Lindenberg","year":"2002","unstructured":"Meyer-Lindenberg, A. et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat. Neurosci. 5, 267\u2013271 (2002).","journal-title":"Nat. Neurosci."},{"key":"16442_CR51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.biopsych.2011.10.009","volume":"71","author":"R Mizrahi","year":"2012","unstructured":"Mizrahi, R. et al. Increased stress-induced dopamine release in psychosis. Biol. Psychiatry 71, 561\u2013567 (2012).","journal-title":"Biol. Psychiatry"},{"key":"16442_CR52","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","volume":"91","author":"J Reith","year":"1994","unstructured":"Reith, J. et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc. Natl. Acad. Sci. 91, 11651\u201311654 (1994).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR53","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.biopsych.2008.12.007","volume":"65","author":"A Abi-Dargham","year":"2009","unstructured":"Abi-Dargham, A., van de Giessen, E., Slifstein, M., Kegeles, L. S. & Laruelle, M. Baseline and amphetamine-stimulated dopamine activity are related in drug-na\u00efve schizophrenic subjects. Biol. Psychiatry 65, 1091\u20131093 (2009).","journal-title":"Biol. Psychiatry"},{"key":"16442_CR54","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","volume":"74","author":"S Jauhar","year":"2017","unstructured":"Jauhar, S. et al. A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiat. 74, 1206 (2017).","journal-title":"JAMA Psychiat."},{"key":"16442_CR55","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/mp.2011.20","volume":"16","author":"O Howes","year":"2011","unstructured":"Howes, O. et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: A PET study. Mol. Psychiatry 16, 885\u2013886 (2011).","journal-title":"Mol. Psychiatry"},{"key":"16442_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01108-y","author":"M Rogdaki","year":"2021","unstructured":"Rogdaki, M. et al. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: A [18F]-DOPA PET study. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-021-01108-y (2021).","journal-title":"Mol. Psychiatry"},{"key":"16442_CR57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon, R. A., Marques, T. R. & Howes, O. D. Schizophrenia\u2014An overview. JAMA Psychiat. 77, 201\u2013210 (2020).","journal-title":"JAMA Psychiat."},{"key":"16442_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.31887\/DCNS.2016.18.1\/shaber","volume":"18","author":"SN Haber","year":"2016","unstructured":"Haber, S. N. Corticostriatal circuitry. Dialogues Clin. Neurosci. 18, 7\u201321 (2016).","journal-title":"Dialogues Clin. Neurosci."},{"key":"16442_CR59","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamapsychiatry.2014.2414","volume":"72","author":"M Slifstein","year":"2015","unstructured":"Slifstein, M. et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: A positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiat. 72, 316\u2013324 (2015).","journal-title":"JAMA Psychiat."},{"key":"16442_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pscychresns.2019.07.005","volume":"291","author":"E D\u2019Ambrosio","year":"2019","unstructured":"D\u2019Ambrosio, E. et al. The effect of a genetic variant at the schizophrenia associated AS3MT\/BORCS7 locus on striatal dopamine function: A PET imaging study. Psychiatry Res. Neuroimaging 291, 34\u201341 (2019).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"16442_CR61","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.biopsych.2013.05.027","volume":"75","author":"MAP Bloomfield","year":"2014","unstructured":"Bloomfield, M. A. P. et al. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol. Psychiatry 75, 470\u2013478 (2014).","journal-title":"Biol. Psychiatry"},{"key":"16442_CR62","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00213-014-3523-4","volume":"231","author":"MAP Bloomfield","year":"2014","unstructured":"Bloomfield, M. A. P., Morgan, C. J. A., Kapur, S., Curran, H. V. & Howes, O. D. The link between dopamine function and apathy in cannabis users: An [18F]-DOPA PET imaging study. Psychopharmacology 231, 2251\u20132259 (2014).","journal-title":"Psychopharmacology"},{"key":"16442_CR63","doi-asserted-by":"publisher","first-page":"e29088","DOI":"10.7554\/eLife.29088","volume":"6","author":"S Froudist-Walsh","year":"2017","unstructured":"Froudist-Walsh, S. et al. The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult life. Elife 6, e29088 (2017).","journal-title":"Elife"},{"key":"16442_CR64","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1038\/tp.2016.270","volume":"7","author":"S Jauhar","year":"2017","unstructured":"Jauhar, S. et al. Regulation of dopaminergic function: An [18F]-DOPA PET apomorphine challenge study in humans. Transl. Psychiatry 7, e1027\u2013e1027 (2017).","journal-title":"Transl. Psychiatry"},{"key":"16442_CR65","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1093\/hmg\/ddy242","volume":"27","author":"T Dahoun","year":"2018","unstructured":"Dahoun, T. et al. The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: An [18F]-DOPA PET study. Hum. Mol. Genet. 27, 3498\u20133506 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"16442_CR66","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1021055617738","volume":"33","author":"B Freeman","year":"2003","unstructured":"Freeman, B. et al. DNA from buccal swabs recruited by mail: Evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav. Genet. 33, 67\u201372 (2003).","journal-title":"Behav. Genet."},{"key":"16442_CR67","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1128","author":"B Zhang","year":"2005","unstructured":"Zhang, B. & Horvath, S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. https:\/\/doi.org\/10.2202\/1544-6115.1128 (2005).","journal-title":"Stat. Appl. Genet. Mol."},{"key":"16442_CR68","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10524","volume":"478","author":"C Colantuoni","year":"2011","unstructured":"Colantuoni, C. et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519\u2013523 (2011).","journal-title":"Nature"},{"key":"16442_CR69","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/nprot.2010.116","volume":"5","author":"CA Anderson","year":"2010","unstructured":"Anderson, C. A. et al. Data quality control in genetic case-control association studies. Nat. Protoc. 5, 1564\u20131573 (2010).","journal-title":"Nat. Protoc."},{"key":"16442_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience 4, 1\u201316 (2015).","journal-title":"Gigascience"},{"key":"16442_CR71","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/gepi.21896","volume":"39","author":"MP Conomos","year":"2015","unstructured":"Conomos, M. P., Miller, M. B. & Thornton, T. A. Robust inference of population structure for ancestry prediction and correction of stratification in the presence of relatedness. Genet. Epidemiol. 39, 276\u2013293 (2015).","journal-title":"Genet. Epidemiol."},{"key":"16442_CR72","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1093\/bioinformatics\/btz567","volume":"35","author":"SM Gogarten","year":"2019","unstructured":"Gogarten, S. M. et al. Genetic association testing using the GENESIS R\/bioconductor package. Bioinformatics 35, 5346\u20135348 (2019).","journal-title":"Bioinformatics"},{"key":"16442_CR73","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/1073858409338217","volume":"15","author":"Y Kumakura","year":"2009","unstructured":"Kumakura, Y. & Cumming, P. PET studies of cerebral levodopa metabolism: A review of clinical findings and modeling approaches. Neuroscientist 15, 635\u2013650 (2009).","journal-title":"Neuroscientist"},{"key":"16442_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-00866-7","author":"M Veronese","year":"2020","unstructured":"Veronese, M. et al. A potential biomarker for treatment stratification in psychosis: Evaluation of an [18F] FDOPA PET imaging approach. Neuropsychopharmacology https:\/\/doi.org\/10.1038\/s41386-020-00866-7 (2020).","journal-title":"Neuropsychopharmacology"},{"key":"16442_CR75","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/00004647-199911000-00003","volume":"19","author":"FE Turkheimer","year":"1999","unstructured":"Turkheimer, F. E., Brett, M., Visvikis, D. & Cunningham, V. J. Multiresolution analysis of emission tomography images in the wavelet domain. J. Cereb. Blood Flow Metab. 19, 1189\u20131208 (1999).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"16442_CR76","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neuroimage.2009.12.058","volume":"50","author":"A Egerton","year":"2010","unstructured":"Egerton, A., Demjaha, A., McGuire, P., Mehta, M. A. & Howes, O. D. The test\u2013retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. Neuroimage 50, 524\u2013531 (2010).","journal-title":"Neuroimage"},{"key":"16442_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez, D. et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 23, 285\u2013300 (2003).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"16442_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","volume":"66","author":"O Howes","year":"2009","unstructured":"Howes, O. et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch. Gen. Psychiatry 66, 13\u201320 (2009).","journal-title":"Arch. Gen. Psychiatry"},{"key":"16442_CR79","unstructured":"Team, R. C. R: A Language and Environment for Statistical Computing (2021)."},{"key":"16442_CR80","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neurobiolaging.2008.05.005","volume":"31","author":"Y Kumakura","year":"2010","unstructured":"Kumakura, Y. et al. Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study. Neurobiol. Aging 31, 447\u2013463 (2010).","journal-title":"Neurobiol. Aging"},{"key":"16442_CR81","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/schbul\/sbx023.081","volume":"43","author":"A Egerton","year":"2017","unstructured":"Egerton, A. et al. Elevated striatal dopamine function in immigrants and their children: A risk mechanism for psychosis. Schizophrenia Bull. 43, 293\u2013301 (2017).","journal-title":"Schizophrenia Bull."},{"key":"16442_CR82","doi-asserted-by":"publisher","first-page":"818574","DOI":"10.3389\/fgene.2022.818574","volume":"13","author":"JA Collister","year":"2022","unstructured":"Collister, J. A., Liu, X. & Clifton, L. calculating polygenic risk scores (PRS) in UK Biobank: A practical guide for epidemiologists. Front. Genet. 13, 818574 (2022).","journal-title":"Front. Genet."},{"key":"16442_CR83","first-page":"241","volume-title":"ggplot2, Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2, Elegant Graphics for Data Analysis 241\u2013253 (Springer, 2016)."},{"key":"16442_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-8456-1","volume-title":"EnvStats: An R Package for Environmental Statistics","author":"SP Millard","year":"2013","unstructured":"Millard, S. P. EnvStats: An R Package for Environmental Statistics (Springer, 2013)."},{"key":"16442_CR85","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1017\/S0033291715002639","volume":"46","author":"G Pergola","year":"2016","unstructured":"Pergola, G. et al. Combined effect of genetic variants in the GluN2B coding gene (GRIN2B) on prefrontal function during working memory performance. Psychol. Med. 46, 1135\u20131150 (2016).","journal-title":"Psychol. Med."},{"key":"16442_CR86","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","volume":"169","author":"A Demjaha","year":"2012","unstructured":"Demjaha, A., Murray, R., McGuire, P., Kapur, S. & Howes, O. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. AJP 169, 1203\u20131210 (2012).","journal-title":"AJP"},{"key":"16442_CR87","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopsych.2018.07.003","volume":"85","author":"S Jauhar","year":"2019","unstructured":"Jauhar, S. et al. The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first-episode psychosis: A positron emission tomography study. Biol. Psychiatry 85, 79\u201387 (2019).","journal-title":"Biol. Psychiatry"},{"key":"16442_CR88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/acps.12825","volume":"137","author":"R McCutcheon","year":"2018","unstructured":"McCutcheon, R. et al. Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia. Acta Psychiatr. Scand. 137, 39\u201346 (2018).","journal-title":"Acta Psychiatr. Scand."},{"key":"16442_CR89","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1523\/JNEUROSCI.4475-07.2008","volume":"28","author":"R Cools","year":"2008","unstructured":"Cools, R., Gibbs, S. E., Miyakawa, A., Jagust, W. & D\u2019Esposito, M. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J. Neurosci. 28, 1208\u20131212 (2008).","journal-title":"J. Neurosci."},{"key":"16442_CR90","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/cercor\/bhn095","volume":"19","author":"SM Landau","year":"2009","unstructured":"Landau, S. M., Lal, R., O\u2019Neil, J. P., Baker, S. & Jagust, W. J. Striatal dopamine and working memory. Cereb. Cortex 19, 445\u2013454 (2009).","journal-title":"Cereb. Cortex"},{"key":"16442_CR91","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/hbm.20325","volume":"28","author":"I Vernaleken","year":"2007","unstructured":"Vernaleken, I. et al. \u2018Prefrontal\u2019 cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: An exploratory [18F]-fluoro-L-DOPA-PET investigation. Hum. Brain Mapp. 28, 931\u2013939 (2007).","journal-title":"Hum. Brain Mapp."},{"key":"16442_CR92","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/hbm.21081","volume":"32","author":"MN Braskie","year":"2011","unstructured":"Braskie, M. N. et al. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Hum. Brain Mapp. 32, 947\u2013961 (2011).","journal-title":"Hum. Brain Mapp."},{"key":"16442_CR93","doi-asserted-by":"publisher","first-page":"14320","DOI":"10.1523\/JNEUROSCI.3729-08.2008","volume":"28","author":"MN Braskie","year":"2008","unstructured":"Braskie, M. N. et al. Relationship of striatal dopamine synthesis capacity to age and cognition. J. Neurosci. 28, 14320\u201314328 (2008).","journal-title":"J. Neurosci."},{"key":"16442_CR94","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41398-018-0114-x","volume":"8","author":"C Ma","year":"2018","unstructured":"Ma, C., Gu, C., Huo, Y., Li, X. & Luo, X.-J. The integrated landscape of causal genes and pathways in schizophrenia. Transl. Psychiatry 8, 67 (2018).","journal-title":"Transl. Psychiatry"},{"key":"16442_CR95","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/ajmg.b.32503","volume":"171","author":"L Whitton","year":"2016","unstructured":"Whitton, L. et al. Cognitive analysis of schizophrenia risk genes that function as epigenetic regulators of gene expression. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 171, 1170\u20131179 (2016).","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"16442_CR96","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cels.2015.11.002","volume":"1","author":"J Li","year":"2015","unstructured":"Li, J. et al. Identification of human neuronal protein complexes reveals biochemical activities and convergent mechanisms of action in autism spectrum disorders. Cell Syst. 1, 361\u2013374 (2015).","journal-title":"Cell Syst."},{"key":"16442_CR97","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3892\/or.2017.5436","volume":"37","author":"Z Wang","year":"2017","unstructured":"Wang, Z. et al. Knockdown of GATAD2A suppresses cell proliferation in thyroid cancer in vitro. Oncol. Rep. 37, 2147\u20132152 (2017).","journal-title":"Oncol. Rep."},{"key":"16442_CR98","doi-asserted-by":"publisher","first-page":"ddx103","DOI":"10.1093\/hmg\/ddx103","volume":"26","author":"JF Fullard","year":"2017","unstructured":"Fullard, J. F. et al. Open chromatin profiling of human postmortem brain infers functional roles for non-coding schizophrenia loci. Hum. Mol. Genet. 26, ddx103 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"16442_CR99","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.cell.2018.05.046","volume":"173","author":"Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2018","unstructured":"Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium et al. Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell 173, 1705\u20131715 (2018).","journal-title":"Cell"},{"key":"16442_CR100","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1006\/mcne.2001.1057","volume":"18","author":"\u00c5 Wall\u00e9n","year":"2001","unstructured":"Wall\u00e9n, \u00c5. et al. Orphan nuclear receptor Nurr1 is essential for ret expression in midbrain dopamine neurons and in the brain stem. Mol. Cell. Neurosci. 18, 649\u2013663 (2001).","journal-title":"Mol. Cell. Neurosci."},{"key":"16442_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(00)00107-8","volume":"80","author":"KY Tseng","year":"2000","unstructured":"Tseng, K. Y. et al. Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice. Mol. Brain Res. 80, 1\u20136 (2000).","journal-title":"Mol. Brain Res."},{"key":"16442_CR102","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1523\/JNEUROSCI.5236-05.2006","volume":"26","author":"S Kim","year":"2006","unstructured":"Kim, S. et al. The Dopamine D<sub>2<\/sub> receptor regulates the development of dopaminergic neurons via extracellular signal-regulated kinase and Nurr1 activation. J. Neurosci. 26, 4567 (2006).","journal-title":"J. Neurosci."},{"key":"16442_CR103","doi-asserted-by":"publisher","first-page":"9023","DOI":"10.1523\/JNEUROSCI.0918-12.2012","volume":"32","author":"A Anzalone","year":"2012","unstructured":"Anzalone, A. et al. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J. Neurosci. 32, 9023\u20139034 (2012).","journal-title":"J. Neurosci."},{"key":"16442_CR104","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1073\/pnas.0138018100","volume":"100","author":"CA Paladini","year":"2003","unstructured":"Paladini, C. A., Robinson, S., Morikawa, H., Williams, J. T. & Palmiter, R. D. Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism. Proc. Natl. Acad. Sci. 100, 2866\u20132871 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"16442_CR105","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.2042-7158.1972.tb09104.x","volume":"24","author":"W Kehr","year":"1972","unstructured":"Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T. & Atack, C. Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744\u2013747 (1972).","journal-title":"J. Pharm. Pharmacol."},{"key":"16442_CR106","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1749-6632.1990.tb32003.x","volume":"604","author":"ME Wolf","year":"1990","unstructured":"Wolf, M. E. & Roth, R. H. Autoreceptor regulation of dopamine synthesis. Ann. N.Y. Acad. Sci. 604, 323\u2013343 (1990).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"16442_CR107","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nn.2862","volume":"14","author":"EP Bello","year":"2011","unstructured":"Bello, E. P. et al. Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat. Neurosci. 14, 1033\u20131038 (2011).","journal-title":"Nat. Neurosci."},{"key":"16442_CR108","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00213-003-1491-1","volume":"168","author":"M Marinelli","year":"2003","unstructured":"Marinelli, M., Cooper, D. C., Baker, L. K. & White, F. J. Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology 168, 84\u201398 (2003).","journal-title":"Psychopharmacology"},{"key":"16442_CR109","doi-asserted-by":"publisher","DOI":"10.1101\/2022.04.14.488129","author":"G Nordio","year":"2022","unstructured":"Nordio, G. et al. Digital data repository and automatic analysis framework for FDOPA PET neuroimaging. Biorxiv https:\/\/doi.org\/10.1101\/2022.04.14.488129 (2022).","journal-title":"Biorxiv"},{"key":"16442_CR110","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pscychresns.2007.11.003","volume":"163","author":"VL Cropley","year":"2008","unstructured":"Cropley, V. L. et al. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA. Psychiatry Res. Neuroimaging 163, 171\u2013182 (2008).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"16442_CR111","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/biomedicines9020108","volume":"9","author":"MR Kilbourn","year":"2021","unstructured":"Kilbourn, M. R. 11C- and 18F-radiotracers for in vivo imaging of the dopamine system: Past: past, present and future. Biomedicines 9, 108 (2021).","journal-title":"Biomedicines"},{"key":"16442_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.05.009","author":"WG Frankle","year":"2022","unstructured":"Frankle, W. G., Himes, M., Mason, N. S., Mathis, C. A. & Narendran, R. Prefrontal and striatal dopamine release are inversely correlated in schizophrenia. Biol. Psychiatry https:\/\/doi.org\/10.1016\/j.biopsych.2022.05.009 (2022).","journal-title":"Biol. Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16442-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16442-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16442-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:22:23Z","timestamp":1669332143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16442-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16442"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16442-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"3 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article. ODH is a part-time employee of H. Lundbeck A\/S and has received investigator-initiated research funding from and\/or participated in advisory\/speaker meetings organised by Angelini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Rand, Recordati, Roche and Viatris\/Mylan. Neither ODH nor his family have holdings\/a financial stake in any pharmaceutical company. ODH has a patent for the use of dopaminergic imaging. JTRW is an investigator on a grant from Takeda Pharmaceuticals Ltd. to Cardiff University, for a project unrelated to the work presented here. The other authors have nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12610"}}